Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.
  • Navigate
  • Specialist
  • Healthcare
    • Sub Sector Focus
    • Investment Themes
    • Portfolio
    • Case Studies
  • Partners
    • About
    • Our Team
    • Responsible Investing
    • People and Culture
  • Insights
  • Investor portal
  • Navigate
  • Specialist
  • Healthcare
    • Sub Sector Focus
    • Investment Themes
    • Portfolio
    • Case Studies
  • Partners
    • About
    • Our Team
    • Responsible Investing
    • People and Culture
  • Insights
  • News + Updates

Investor Relations

IR Portal Investor Privacy Notice

Global Healthcare Opportunities, or GHO Capital Partners Advisory Ltd., is a leading specialist healthcare investment advisor based in London.

Contact us
  • LinkedIn

News + Updates

GHO Capital appoints Olav König as Head of Investor Relations
GHO Capital Updates

GHO Capital appoints Olav König as Head of Investor Relations

+Read Update
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
Biocare Medical

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

+Read Update
GHO Capital and CBC Group to Create World’s Largest Dedicated Healthcare Investment Firm
GHO Capital Updates

GHO Capital and CBC Group to Create World’s Largest Dedicated Healthcare Investment Firm

+Read Update
Alcami to Acquire Contract Packaging Organization Tjoapack
Alcami

Alcami to Acquire Contract Packaging Organization Tjoapack

+Read Update
GHO Capital completes sale of VISUfarma to Lupin
VISUfarma

GHO Capital completes sale of VISUfarma to Lupin

+Read Update
GHO Capital and Excellere Partners Sell Biocare Medical to Agilent Technologies
Biocare Medical

GHO Capital and Excellere Partners Sell Biocare Medical to Agilent Technologies

+Read Update
GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare
GHO Capital Updates

GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare

+Read Update
GHO Capital Sells VISUfarma to Lupin
VISUfarma

GHO Capital Sells VISUfarma to Lupin

+Read Update
  • Privacy Policy
  • Contact us
  • Website Terms and Conditions
  • Modern Slavery and Human Trafficking Statement
  • Fraudulent Activity Notice

Possible Offer for [Daffodil] PLC

Sign-up to receive the latest updates to your inbox

By clicking submit you consent to receiving email news, alerts, updates and marketing information from or on behalf of GHO. We will process your personal data in accordance with applicable data protection laws. You can unsubscribe at any time by clicking the link at the bottom of each email.

GHO Capital
  • +44 20 3700 7440
  • [email protected]
  • 21 St James’s Square
    London SW1Y 4JZ

    For media enquiries, please contact [email protected]




    Directions
  • LinkedIn
  • Privacy Policy
  • Contact us
  • Website Terms and Conditions
  • Modern Slavery and Human Trafficking Statement
  • Fraudulent Activity Notice
© 2026 — GHO Capital. All rights reserved.
Website by Alchemy Digital